ASCO GU 2024

ASCO GU 2024
January 25-27, 2024
San Francisco, CA

American Society of Clinical Oncology Genitourinary Cancers Symposium.

Explore more information for Gilead Oncology therapies
Results (1)

A Retrospective Cohort Study to Monitor Real-World Safety in Patients with Locally Advanced or Metastatic Urothelial Carcinoma (LA/mUC) Treated with Sacituzumab Govitecan (SG) in the United States